Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV000722066 | SCV000994939 | uncertain significance | Capillary malformation-arteriovenous malformation 2 | 2019-03-29 | criteria provided, single submitter | curation | This variant is interpreted as Uncertain significance for Capillary malformation-arteriovenous malformation 2. The following ACMG Tag(s) were applied: PM2: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PM1: Located in a mutational hot spot and/or critical and well-established functional domain (e.g.,active site of an enzyme) without benign variation. PP3: Multiple lines of computational evidence support a deleterious effect on the gene or gene product. |
OMIM | RCV000722066 | SCV000853246 | pathogenic | Capillary malformation-arteriovenous malformation 2 | 2018-11-21 | no assertion criteria provided | literature only | |
Prevention |
RCV004751678 | SCV005341467 | uncertain significance | EPHB4-related disorder | 2024-03-27 | no assertion criteria provided | clinical testing | The EPHB4 c.319T>C variant is predicted to result in the amino acid substitution p.Cys107Arg. This variant has been reported in a patient with vein of Galen malformation (Patient AA5718 in Vivanti et al. 2018. PubMed ID: 29444212). To our knowledge, this variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |